This is further supported by a previous study showing that the serum adiponectin/leptin ratio serves as a reliable marker of adipose tissue dysfunction and may effectively estimate cardiometabolic risk linked to obesity and metabolic syndrome, enabling the identification of a greater number of at-risk individuals40. The gene discussed is LEP; the disease is obesity disorder.